Document is current
Any future updates will be listed below
-
Authors
Blakey, John D.
Cecchi, Lorenzo
Domingo, Christian
D’Urzo, Tony D.
Singh, Dave
Verma, Manish
-
Funding
Funding for this research was provided by:
GSK
- License Information
-
More Information
Article History
Received: 4 November 2025
Accepted: 27 January 2026
First Online: 10 March 2026
Declarations
:
: John Blakey reports, in the last 3 years, personal and institutional consulting fees or payment for educational activities from AstraZeneca, Boehringer Ingelheim, Chiesi, Sanofi, and GSK; support for attending meetings and/or travel from AstraZeneca and GSK; receipt of medical writing support from GSK and Teva; payment to their institution for advisory work from Asthma Australia. Lorenzo Cecchi reports consulting fees from GSK and Novartis; honoraria for lectures from AstraZeneca, Chiesi, Menarini, Novartis, Sanofi, Thermofisher, and GSK; support for attending meetings from Menarini; grants for scientific boards from GSK, FIRMA, Menarini, and Thermofisher. Christian Domingo declares having received financial aid for travel support and speakers’ bureaus from ALK-Abello, Allergy Therapeutics, AstraZeneca, Chiesi, GSK, Hall Allergy, Inmunotek, Menarini Diagnostics, MSD, Novartis, Roxall, Sanofi, and Stallergenes. Tony D’Urzo has received research, consulting and lecturing fees from AstraZeneca, COVIS Pharma Canada, GSK, Sanofigenzyme, TEVA Canada, and Valeopharma Canada. Dave Singh has received sponsorship to attend and speak at international meetings, honoraria for lecturing or attending advisory boards from Adovate, Almirall, Anaveon, Apogee, Arcutis Biotherapeutics, Arrowhead, AstraZeneca, Belenos Biosciences, Bial, Celldex, Chiesi, Cipla, CONNECT Biopharm, Covis, DevPro Biopharma LCC, Elpen, Empirico, EpiEndo, Generate Biomedicines, GlaxoSmithKline, Glenmark, Jasper, Kinaset Therapeutics, KOLON, Kymera, Lupin, Melodia, Menarini, MicroA, OM Pharma, OrientEuroPharma, Recipharm, Revolo, RIGImmune Inc, Roche, Roivant Sciences, Sanofi, Sitryx, Synairgen, Tetherex, UCB, Upstream, Verona Pharma, Winward, Zura Bio, Zymeworks. Manish Verma is a GSK employee and holds financial equities in GSK.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
